ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

LOTRISONE
Skin infections (topicals)
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

LOTRISONE Rx

Generic Name and Formulations:
Betamethasone (as dipropionate) 0.05%, clotrimazole 1%; crm; lotion.

Company:
Merck & Co., Inc.

Therapeutic Use:

Indications for LOTRISONE:

Tinea pedis, t. cruris, t. corporis.

Adult:

T. cruris, t. corporis: apply thin film twice daily for 1 week; max 2 weeks. T. pedis: apply sufficient amount twice daily for 2 weeks; max 4 weeks. Max 45g (crm), 45mL (lotion) per week. Do not occlude.

Children:

<17yrs: not recommended.

Warnings/Precautions:

Avoid eyes. Do not use for diaper dermatitis. Risk of HPA axis suppression with high-potency steroids, prolonged use, application to large surface area, use of occlusive dressings, altered skin barrier, liver failure, young age; discontinue gradually, or reduce dose or potency if occurs. Increased risk of posterior subcapsular cataracts and glaucoma; monitor for visual symptoms. Thinning skin. Reevaluate periodically. Pregnancy (Cat.C). Nursing mothers.

Pharmacological Class:

Steroid + azole antifungal.

Adverse Reactions:

Rash, edema, secondary infections; HPA axis suppression (esp. in children), skin atrophy.

How Supplied:

Crm—15g, 45g; Lotion—30mL


Data provided by MPR.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs